[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Foundation for Orthopaedic Research and Education\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":115},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,41,66,90],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100468769","outcomes-of-treatment-using-the-ermi-shoulder-flexionater--100468769",false,"NCT05384093","Outcomes of Treatment Using the ERMI Shoulder Flexionater ®","Outcomes of Treatment Using the ERMI Shoulder Flexionater®","For Study Group 1- Adhesive Capsulitis (AC)\n\nInclusion Criteria:\n\n* Exhibits symptoms of adhesive capsulitis i. Shoulder pain with limited motion for more than one month ii. AND ≤ 30 degrees external rotation with arm at side iii. AND ≤ 130 degrees forward flexion d. Cortisone shot for all patients\n\nExclusion Criteria:\n\n* a. No prior shoulder surgery b. Infection c. Rheumatoid arthritis d. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder\n\nFor Study Group 2 - Postoperative Shoulder Stiffness Study (POS)\n\nInclusion Criteria:\n\nc. Is not recovering normally based on objective criteria set for screening process i. Step 1 - Follow patients -all post-op patients with indicated procedures (see # 7 for list.) ii. Step 2 - Screen Patients -does patient meets inclusion criteria at 6 weeks or 3 months of follow-up?\n\n1. \\\u003C 15 degrees external rotation with arm at side at 6 weeks post-op\n2. OR \\\u003C 90 degrees forward flexion at 3 months post-op iii. Step 3 - Enroll patients that meet inclusion criteria and assign group\n\nExclusion Criteria:\n\na. Revision surgery b. Infection c. Rheumatoid arthritis\n\n7\\. Procedures included\n\n1. Shoulder arthroscopic procedures (29827, 29828, 29823,29824, 29826)\n2. ORIF Humerus fracture (23615)\n\n   For Study Group 3, Secondary Surgery Study (SAM)\n\n   Inclusion Criteria:\n3. Underwent a manipulation under anesthesia or a lysis of adhesions procedure\n\nExclusion Criteria:\n\na. Infection b. Rheumatoid arthritis c. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder\n\n7\\. Procedures included\n\n1. Manipulation under anesthesia (23700)\n2. Lysis of adhesions (29825)",true,"ALL","18 Years",{"count":20,"type":21},210,"ESTIMATED","INTERVENTIONAL",[24],"NA","Study 1 - Adhesive Capsulitis Study - 110 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.\n\nStudy 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.\n\nStudy 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.",[27],"Adhesive Capsulitis of Shoulder","RECRUITING","2025-08-04",{"date":31,"type":32},"2025-08-07","ACTUAL",{"date":34,"type":32},"2019-06-25",{"date":36,"type":21},"2026-06-25",{"name":38,"class":39},"Foundation for Orthopaedic Research and Education","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":22,"phases":51,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":40},"100583440","woodcasting-versus-thermoplast-splint-in-cmc-arthroplasty-100583440","NCT06876350","Woodcasting Versus Thermoplast Splint in CMC Arthroplasty","Patient Satisfaction for Post-Operative Carpometacarpal Arthroplasty: Wood Casting Versus Thermoplastic Splint","Woodcast","Inclusion Criteria:\n\n* Patients over the age of 18 years old.\n* Intact Medical Decision Making\n* Eligible for Surgical Intervention\n* Willing to comply with all aspects of the treatment and evaluation schedule over 6 weeks\n\nExclusion Criteria:\n\n* Pregnant Women\n* Deemed Unsuitable by Principal Investigator",{"count":50,"type":21},26,[24],"This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.",[54],"Carpometacarpal (CMC) Joint Arthritis",[56,57],"Randomized","Hand and Upper Extremity","2025-03-13",{"date":60,"type":32},"2025-03-17",{"date":62,"type":32},"2024-10-03",{"date":64,"type":21},"2025-06-30",{"name":38,"class":39},{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":74,"targetDuration":4,"studyType":22,"phases":76,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":40},"100567069","arvis-tka-vs-conventional-tka-100567069","NCT06663384","ARVIS TKA vs Conventional TKA","A Prospective Study Using Augmented Reality Versus Conventional Jig Controls in Total Knee Arthroplasty for Osteoarthritis","ARVIS","Inclusion Criteria:\n\n* Age over 18 years old\n* Scheduled for primary conventional TKA with kinematic alignment\n* Primary Diagnosis of Osteoarthritis (Killgren Lawrence Grade \\> III) on affected side\n* Able to provide informed consent\n\nExclusion Criteria:\n\n1. Patients with a previous operation of the same knee, including ACL reconstruction, fracture fixation, previous arthroplasty.\n2. Patients that had a conversion to a different procedure intraoperatively or shortly after the TKA.\n3. Diagnosed with greater than Killgren Lawrence Grade II OA on the contralateral knee\n4. Patients that did not complete the TKA.\n5. Patients the Investigator deems not able to follow through with study requirements such as follow-up visits or PROM's.",{"count":75,"type":21},50,[24],"This study is a pilot analysis of a novel augmented reality guidance platform, the augmented reality visualization and information system (ARVIS, Insight Medical), with aims to demonstrate accuracy of bone resection and implant alignment during kinematic alignment total knee arthroplasty.",[79],"Osteoarthritis",[81],"osteoarthritis of knee, Total Knee Replacement","2024-12-04",{"date":84,"type":32},"2024-12-09",{"date":86,"type":32},"2024-12-01",{"date":88,"type":21},"2027-11-01",{"name":38,"class":39},{"id":91,"slug":92,"hasResults":11,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":96,"eligibilityCriteria":97,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":98,"targetDuration":4,"studyType":22,"phases":100,"briefSummary":102,"conditions":103,"keywords":105,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":109,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":40},"100508900","phase-1-optimal-anesthetic-for-corticosteroid-injections-for-knee-osteoarthritis-100508900","NCT05906433","Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis","Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis.","Injections","Inclusion Criteria:\n\n1. Patients must be 18 years of age and be able to consent for themselves.\n2. OA grade Kellgren Lawrence Stage II or III.\n3. Diagnosis of primary osteoarthritis.\n\nExclusion Criteria:\n\n1. Patients with other forms of arthritis such as inflammatory arthritis.\n2. History of narcotic use for the past 6 months.\n3. Kellgren Lawrence arthritis grade 1 or 4.\n4. Pregnant women and prisoners.",{"count":99,"type":21},75,[101],"PHASE1","To evaluate pain relief from corticosteroid injection with and without anesthetic as well as with variable volume of anesthetic. Pain relief will be measured using the VAS pain score at the time of the injection as well as several time points following the injection to capture pain relief longevity. The investigators intend to evaluate how well the patients tolerate corticosteroid mixtures without anesthetic as well as with different volumes of anesthetic. Primary measure will be the time from procedure when postoperative status is considered success (as measured by global perceived improvement score).",[104],"Knee Osteoarthritis",[106,107,108],"knee injection","Knee osteoarthritis","corticosteroid",{"date":84,"type":32},{"date":111,"type":32},"2023-06-01",{"date":113,"type":21},"2025-12-01",{"name":38,"class":39},""]